Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Design, expression, and processing of epitomized hepatitis C virus-encoded CTL epitopes.
Anti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026.
Towards novel S-DABOC inhibitors: synthesis, biological investigation, and molecular modeling studies.
Darunavir inhibitory quotient predicts the 48-week virological response to darunavir-based salvage therapy in human immunodeficiency virus-infected protease inhibitor-experienced patients.
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
Inhibition of human immunodeficiency virus type 1 infection in macrophages by an alpha-v integrin blocking antibody.
Multiple products derived from two CCL4 loci: high incidence of a new polymorphism in HIV+ patients.